Characteristics . | Non-MSM . | MSM . |
---|---|---|
Years of diagnosis | ||
Years before 1990 | 187 (3.08) | 408 (6.80) |
Years between 1991 and 2000 | 1395 (22.96) | 1208 (20.13) |
Years between 2000 and 2010 | 2926 (48.15) | 2737 (45.61) |
Years after 2011 | 1569 (25.82) | 1648 (27.46) |
Race* | ||
White | 247 (4.06) | 1672 (27.86) |
Black | 5294 (87.12) | 3357 (55.94) |
Hispanic | 269 (4.43) | 637 (10.61) |
Other | 267 (4.39) | 335 (5.58) |
Age at diagnosis (years) | ||
Pediatric | 142 (2.34) | 0 (0) |
13–19 | 249 (4.10) | 277 (4.62) |
20–24 | 572 (9.41) | 1019 (16.98) |
25–29 | 722 (11.88) | 1195 (19.91) |
30–39 | 1785 (29.37) | 1923 (32.04) |
40–49 | 1606 (26.43) | 1151 (19.18) |
50–59 | 713 (11.73) | 351 (5.85) |
≥60 | 262 (4.31) | 77 (1.28) |
Missing | 26 (0.43) | 8 (0.13) |
Linkage to care | ||
Linked within 3 months | 3527 (58.04) | 3180 (52.94) |
Linked 3–6 months | 248 (4.08) | 238 (3.96) |
Linked 6–12 months | 275 (4.53) | 289 (4.81) |
Linked after 12 months | 1886 (31.04) | 2232 (37.16) |
Missing linkage information or not linked to care | 141 (2.32) | 62 (1.03) |
Retention status | ||
Not retained | 1328 (21.85) | 1369 (22.81) |
Retained | 4749 (78.15) | 4632 (77.19) |
Latest viral suppression status of PLHIV | ||
Not suppressed | 698 (11.49) | 536 (8.93) |
Suppressed | 3942 (64.87) | 4008 (66.79) |
Unknown | 1437 (23.65) | 1457 (24.28) |
Global Moran’s I*** | 0.533 | 0.417 |
Characteristics . | Non-MSM . | MSM . |
---|---|---|
Years of diagnosis | ||
Years before 1990 | 187 (3.08) | 408 (6.80) |
Years between 1991 and 2000 | 1395 (22.96) | 1208 (20.13) |
Years between 2000 and 2010 | 2926 (48.15) | 2737 (45.61) |
Years after 2011 | 1569 (25.82) | 1648 (27.46) |
Race* | ||
White | 247 (4.06) | 1672 (27.86) |
Black | 5294 (87.12) | 3357 (55.94) |
Hispanic | 269 (4.43) | 637 (10.61) |
Other | 267 (4.39) | 335 (5.58) |
Age at diagnosis (years) | ||
Pediatric | 142 (2.34) | 0 (0) |
13–19 | 249 (4.10) | 277 (4.62) |
20–24 | 572 (9.41) | 1019 (16.98) |
25–29 | 722 (11.88) | 1195 (19.91) |
30–39 | 1785 (29.37) | 1923 (32.04) |
40–49 | 1606 (26.43) | 1151 (19.18) |
50–59 | 713 (11.73) | 351 (5.85) |
≥60 | 262 (4.31) | 77 (1.28) |
Missing | 26 (0.43) | 8 (0.13) |
Linkage to care | ||
Linked within 3 months | 3527 (58.04) | 3180 (52.94) |
Linked 3–6 months | 248 (4.08) | 238 (3.96) |
Linked 6–12 months | 275 (4.53) | 289 (4.81) |
Linked after 12 months | 1886 (31.04) | 2232 (37.16) |
Missing linkage information or not linked to care | 141 (2.32) | 62 (1.03) |
Retention status | ||
Not retained | 1328 (21.85) | 1369 (22.81) |
Retained | 4749 (78.15) | 4632 (77.19) |
Latest viral suppression status of PLHIV | ||
Not suppressed | 698 (11.49) | 536 (8.93) |
Suppressed | 3942 (64.87) | 4008 (66.79) |
Unknown | 1437 (23.65) | 1457 (24.28) |
Global Moran’s I*** | 0.533 | 0.417 |
Data are presented as n (%) unless otherwise indicated. Abbreviations: DC, District of Columbia; HIV, human immunodeficiency virus; MSM, men who have sex with men; PLHIV, people living with human immunodeficiency virus.
Characteristics . | Non-MSM . | MSM . |
---|---|---|
Years of diagnosis | ||
Years before 1990 | 187 (3.08) | 408 (6.80) |
Years between 1991 and 2000 | 1395 (22.96) | 1208 (20.13) |
Years between 2000 and 2010 | 2926 (48.15) | 2737 (45.61) |
Years after 2011 | 1569 (25.82) | 1648 (27.46) |
Race* | ||
White | 247 (4.06) | 1672 (27.86) |
Black | 5294 (87.12) | 3357 (55.94) |
Hispanic | 269 (4.43) | 637 (10.61) |
Other | 267 (4.39) | 335 (5.58) |
Age at diagnosis (years) | ||
Pediatric | 142 (2.34) | 0 (0) |
13–19 | 249 (4.10) | 277 (4.62) |
20–24 | 572 (9.41) | 1019 (16.98) |
25–29 | 722 (11.88) | 1195 (19.91) |
30–39 | 1785 (29.37) | 1923 (32.04) |
40–49 | 1606 (26.43) | 1151 (19.18) |
50–59 | 713 (11.73) | 351 (5.85) |
≥60 | 262 (4.31) | 77 (1.28) |
Missing | 26 (0.43) | 8 (0.13) |
Linkage to care | ||
Linked within 3 months | 3527 (58.04) | 3180 (52.94) |
Linked 3–6 months | 248 (4.08) | 238 (3.96) |
Linked 6–12 months | 275 (4.53) | 289 (4.81) |
Linked after 12 months | 1886 (31.04) | 2232 (37.16) |
Missing linkage information or not linked to care | 141 (2.32) | 62 (1.03) |
Retention status | ||
Not retained | 1328 (21.85) | 1369 (22.81) |
Retained | 4749 (78.15) | 4632 (77.19) |
Latest viral suppression status of PLHIV | ||
Not suppressed | 698 (11.49) | 536 (8.93) |
Suppressed | 3942 (64.87) | 4008 (66.79) |
Unknown | 1437 (23.65) | 1457 (24.28) |
Global Moran’s I*** | 0.533 | 0.417 |
Characteristics . | Non-MSM . | MSM . |
---|---|---|
Years of diagnosis | ||
Years before 1990 | 187 (3.08) | 408 (6.80) |
Years between 1991 and 2000 | 1395 (22.96) | 1208 (20.13) |
Years between 2000 and 2010 | 2926 (48.15) | 2737 (45.61) |
Years after 2011 | 1569 (25.82) | 1648 (27.46) |
Race* | ||
White | 247 (4.06) | 1672 (27.86) |
Black | 5294 (87.12) | 3357 (55.94) |
Hispanic | 269 (4.43) | 637 (10.61) |
Other | 267 (4.39) | 335 (5.58) |
Age at diagnosis (years) | ||
Pediatric | 142 (2.34) | 0 (0) |
13–19 | 249 (4.10) | 277 (4.62) |
20–24 | 572 (9.41) | 1019 (16.98) |
25–29 | 722 (11.88) | 1195 (19.91) |
30–39 | 1785 (29.37) | 1923 (32.04) |
40–49 | 1606 (26.43) | 1151 (19.18) |
50–59 | 713 (11.73) | 351 (5.85) |
≥60 | 262 (4.31) | 77 (1.28) |
Missing | 26 (0.43) | 8 (0.13) |
Linkage to care | ||
Linked within 3 months | 3527 (58.04) | 3180 (52.94) |
Linked 3–6 months | 248 (4.08) | 238 (3.96) |
Linked 6–12 months | 275 (4.53) | 289 (4.81) |
Linked after 12 months | 1886 (31.04) | 2232 (37.16) |
Missing linkage information or not linked to care | 141 (2.32) | 62 (1.03) |
Retention status | ||
Not retained | 1328 (21.85) | 1369 (22.81) |
Retained | 4749 (78.15) | 4632 (77.19) |
Latest viral suppression status of PLHIV | ||
Not suppressed | 698 (11.49) | 536 (8.93) |
Suppressed | 3942 (64.87) | 4008 (66.79) |
Unknown | 1437 (23.65) | 1457 (24.28) |
Global Moran’s I*** | 0.533 | 0.417 |
Data are presented as n (%) unless otherwise indicated. Abbreviations: DC, District of Columbia; HIV, human immunodeficiency virus; MSM, men who have sex with men; PLHIV, people living with human immunodeficiency virus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.